An improved strategy for analysis of lipid molecules utilising a reversed phase C30 UHPLC column and scheduled MS/MS acquisition. (2021)
Attributed to:
Integrating innovative technologies for genotyping and phenotyping in stratified medicine
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.talanta.2021.122262
PubMed Identifier: 33838772
Publication URI: http://europepmc.org/abstract/MED/33838772
Type: Journal Article/Review
Volume: 229
Parent Publication: Talanta
ISSN: 0039-9140